Search
LAVA Therapeutics NV
LVTXAdd to Watchlist
1.740USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
45.77MMarket Cap
LossP/E TTM
More Details of LAVA Therapeutics NV Company
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA Therapeutics NV Info
Ticker SymbolLVTX
Company nameLAVA Therapeutics NV
IPO dateMar 25, 2021
CEOMr. Stephen A. Hurly
Number of employees34
Security typeOrdinary Share
Fiscal year-endMar 25
AddressYalelaan 60
CityUTRECHT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryNetherlands
Postal code3584 CM
Phone31850163100
Websitehttps://www.lavatherapeutics.com/
Ticker SymbolLVTX
IPO dateMar 25, 2021
CEOMr. Stephen A. Hurly
Company Executives of LAVA Therapeutics NV
Name
Name/Position
Position
Shareholding
Change
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
-100.00%
Mr. Edward F. Smith
Mr. Edward F. Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
FAQs
Who are the top five shareholders of LAVA Therapeutics NV?
The top five shareholders of LAVA Therapeutics NV are: Dr. Kapil Dhingra, M.D.
How many institutions hold shares of LAVA Therapeutics NV (LVTX)?
As of 2025Q4, 49 institutions hold shares of LAVA Therapeutics NV, with a combined market value of approximately 7.26M, accounting for 27.59% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -4778197.00.